T. Beckham

发表

Acid ceramidase induces sphingosine kinase 1/S1P receptor 2-mediated activation of oncogenic Akt signaling

D. Troyer, Y. Shao, J. Norris, 2013, Oncogenesis.

Acid ceramidase upregulation in prostate cancer cells confers resistance to radiation: AC inhibition, a potential radiosensitizer.

A. Bielawska, Y. Hannun, Jun Li, 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

Platinum‐based regimens versus cetuximab in definitive chemoradiation for human papillomavirus‐unrelated head and neck cancer

N. Lee, D. Pfister, N. Riaz, 2020, International journal of cancer.

Clinical evaluation of 4D MRI in the delineation of gross and internal tumor volumes in comparison with 4DCT

J. Mechalakos, Guang Li, M. Hunt, 2019, Journal of applied clinical medical physics.

An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma

P. Brown, P. Brastianos, J. Brugarolas, 2022, CA: a cancer journal for clinicians.

LCL124, a Cationic Analog of Ceramide, Selectively Induces Pancreatic Cancer Cell Death by Accumulating in Mitochondria

A. Bielawska, P. Lu, B. Ogretmen, 2013, The Journal of Pharmacology and Experimental Therapeutics.

Interdiction of sphingolipid metabolism to improve standard cancer therapies.

J. Norris, Joseph C. Cheng, T. Beckham, 2013, Advances in cancer research.

Intensity-Modulated Radiation Therapy With or Without Concurrent Chemotherapy in Nonanaplastic Thyroid Cancer with Unresectable or Gross Residual Disease.

N. Lee, R. Wong, N. Riaz, 2018, Thyroid : official journal of the American Thyroid Association.

Renal Function Outcomes of High-risk Neuroblastoma Patients Undergoing Radiation Therapy.

M. LaQuaglia, S. Wolden, B. Kushner, 2017, International journal of radiation oncology, biology, physics.

Targeting sphingolipid metabolism in head and neck cancer: rational therapeutic potentials

S. Hoffman, J. Norris, Joseph C. Cheng, 2010, Expert opinion on therapeutic targets.

Excellent Outcomes with Surgery or Radiotherapy in the Management of Castleman Disease Including a Case of Oligocentric Disease.

J. Yahalom, A. Noy, K. Chau, 2020, Clinical lymphoma, myeloma & leukemia.

Safety and Efficacy of Dose-Escalated Radiation Therapy With a Simultaneous Integrated Boost for the Treatment of Spinal Metastases.

M. McAleer, L. Rhines, B. Amini, 2022, Practical radiation oncology.

Sphingosine 1-Phosphate Receptor 2 Regulates the Migration, Proliferation, and Differentiation of Mesenchymal Stem Cells

P. Lu, J. Norris, Joseph C. Cheng, 2015, International journal of stem cell research and therapy.

Treatment modalities and outcomes of Fanconi anemia patients with head and neck squamous cell carcinoma: Series of 9 cases and review of the literature

N. Lee, Bhuvanesh Singh, N. Riaz, 2019, Head & neck.

Evaluation of Acid Ceramidase Overexpression-Induced Activation of the Oncogenic Akt Pathway in Prostate Cancer

T. Beckham, 2014 .

Acid Ceramidase Promotes Nuclear Export of PTEN through Sphingosine 1-Phosphate Mediated Akt Signaling

P. Lu, J. Norris, Joseph C. Cheng, 2013, PloS one.

Autophagy is increased in prostate cancer cells over-expressing acid ceramidase and enhances resistance to C6-ceramide

J. Norris, Joseph C. Cheng, T. Beckham, 2010, Prostate Cancer and Prostatic Diseases.

Radiation-induced acid ceramidase confers prostate cancer resistance and tumor relapse.

A. Bielawska, P. Lu, K. Armeson, 2013, The Journal of clinical investigation.

Long-term survival in patients with metastatic head and neck squamous cell carcinoma treated with metastasis-directed therapy

N. Lee, N. Riaz, D. Goldman, 2019, British Journal of Cancer.

Acid ceramidase upregulation in prostate cancer: role in tumor development and implications for therapy

A. Bielawska, Y. Hannun, J. Norris, 2009, Expert opinion on therapeutic targets.

Acid ceramidase‐mediated production of sphingosine 1‐phosphate promotes prostate cancer invasion through upregulation of cathepsin B

Y. Hannun, P. Lu, S. Hoffman, 2012, International journal of cancer.

Metastasis-directed therapy for oligometastasis and beyond

D. Gomez, C. Tsai, T. Beckham, 2020, British journal of cancer.

Stereotactic body radiation therapy for oligometastatic renal cell carcinoma: improving outcomes in an otherwise radioresistant malignancy.

B. Imber, C. Simone, T. Beckham, 2019, Annals of translational medicine.

Bioactivities of gossypol, 6-methoxygossypol, and 6,6'-dimethoxygossypol.

Feng Chen, Xi Wang, James C. Morris, 2008, Journal of Agricultural and Food Chemistry.

Pretreatment albumin may aid in patient selection for intrahepatic Y-90 microsphere transarterial radioembolization (TARE) for malignancies of the liver.

M. B. Anderson, T. Beckham, M. Guimaraes, 2017, Journal of gastrointestinal oncology.

Brain Metastases from Biliary Tract Cancer: Case Series and Clinicogenomic Analysis

E. Holliday, C. Taniguchi, J. Vauthey, 2022, The oncologist.

Outcomes of surgery and postoperative radiation therapy in managing medullary thyroid carcinoma

N. Lee, R. Wong, J. Plukker, 2019, Journal of surgical oncology.

Safety and efficacy of salvage conventional re-irradiation following stereotactic radiosurgery for spine metastases

L. Rhines, B. Amini, T. Briere, 2023, Radiation oncology journal.

Safety and Efficacy of Dose-Escalated Radiation Therapy With a Simultaneous Integrated Boost for the Treatment of Spinal Metastases.

M. McAleer, L. Rhines, B. Amini, 2022, Practical radiation oncology.